Health Care

Discover how VentriPoint Diagnostics transforms heart disease diagnosis with 3‑D imaging tech, boosting accuracy and shaping the future of cardiac care.

Explore Medexus Pharmaceuticals Inc., a Toronto‑listed firm specializing in rheumatology, oncology, and pediatrics—driving innovation in North America’s pharma sector.

Explore Auxly Cannabis Group’s growth in the healthcare cannabis sector—market cap, P/E, global reach, and sustainable innovation driving investor confidence.

Hemostemix Inc. advances blood‑derived cell therapies, navigating biotech volatility and clinical milestones to unlock new treatments for severe medical conditions.

Vertex Pharmaceuticals names new CFO, boosts shareholder stake, and reinforces its biotech leadership—discover how these moves shape the company’s growth and market outlook.

Explore Biomea Fusion’s breakthrough in irreversible small‑molecule cancer drugs—personalized therapy, clinical progress, and investor insight.

Explore Cervomed Inc.’s neurodegenerative drug pipeline—Alzheimer’s and Lewy body dementia—while analyzing its biotech stock performance and future upside.

Regeneron’s stock faces mixed signals amid cost‑control pressure; analysts keep ratings steady while the firm navigates pricing mandates and a growing PCSK9 market.

EyePoint Pharma focuses on breakthrough drug‑device solutions for eye diseases, navigating biotech volatility while aiming to improve patient outcomes worldwide.

How Cronos Group’s $75 M Tectonic hack halted its blockchain, risked CRO token liquidity, and sparked a strategic pivot toward stablecoins.